Episode Details
Back to Episodes
JNJ Holds Strong Near 52-Week High Amid Mixed Market Signals and Geopolitical Tensions
Published 1 month, 3 weeks ago
Description
# Johnson & Johnson Stock Analysis: JNJ Trading at $240.40 with Analyst Upgrades | March 2026 Market Update
Discover the latest **Johnson & Johnson (JNJ) stock analysis** as shares trade at $240.40 on March 10, 2026. This comprehensive podcast episode breaks down JNJ's current market position, featuring recent analyst upgrades from Wolfe Research and Daiwa Capital Markets.
In this episode, we examine:
- **JNJ stock price movement**: Up 0.32% with trading volume exceeding 7.1 million shares
- **Analyst consensus and price targets**: 26 analysts project targets averaging $199-$237, with recent upgrades to "outperform" and "strong buy" ratings
- **Dividend information**: $1.30 quarterly dividend with 0.636% yield
- **Market context**: How rising oil prices ($119/barrel) amid Iran tensions may impact healthcare sector margins
- **52-week performance**: Stock trading near its high of $248.56
Whether you're a Johnson & Johnson shareholder, healthcare sector investor, or market analyst, this episode provides essential insights into JNJ's fundamentals and technical position. Data sourced from Tickeron, MarketBeat, StockAnalysis, and Johnson & Johnson investor relations.
**Subscribe for daily stock market analysis and investment insights.**
*A Quiet Please Studios production | Visit quietplease.ai for more financial podcasts*
**Keywords**: Johnson & Johnson stock, JNJ stock analysis, healthcare stocks, dividend stocks, pharmaceutical stocks, stock market analysis 2026
For more http://www.quietplease.ai
Stock up on these deals
https://amzn.to/3QFpYIX
This content was created in partnership and with the help of Artificial Intelligence AI
This episode includes AI-generated content.
Discover the latest **Johnson & Johnson (JNJ) stock analysis** as shares trade at $240.40 on March 10, 2026. This comprehensive podcast episode breaks down JNJ's current market position, featuring recent analyst upgrades from Wolfe Research and Daiwa Capital Markets.
In this episode, we examine:
- **JNJ stock price movement**: Up 0.32% with trading volume exceeding 7.1 million shares
- **Analyst consensus and price targets**: 26 analysts project targets averaging $199-$237, with recent upgrades to "outperform" and "strong buy" ratings
- **Dividend information**: $1.30 quarterly dividend with 0.636% yield
- **Market context**: How rising oil prices ($119/barrel) amid Iran tensions may impact healthcare sector margins
- **52-week performance**: Stock trading near its high of $248.56
Whether you're a Johnson & Johnson shareholder, healthcare sector investor, or market analyst, this episode provides essential insights into JNJ's fundamentals and technical position. Data sourced from Tickeron, MarketBeat, StockAnalysis, and Johnson & Johnson investor relations.
**Subscribe for daily stock market analysis and investment insights.**
*A Quiet Please Studios production | Visit quietplease.ai for more financial podcasts*
**Keywords**: Johnson & Johnson stock, JNJ stock analysis, healthcare stocks, dividend stocks, pharmaceutical stocks, stock market analysis 2026
For more http://www.quietplease.ai
Stock up on these deals
https://amzn.to/3QFpYIX
This content was created in partnership and with the help of Artificial Intelligence AI
This episode includes AI-generated content.